{"name":"Egle Therapeutics","slug":"egle-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5temxUUGJOMV9BVXQ1dU9zT0d1T0ZYNF9uNWRxWTgxZFducjhId3BLVnhrLXQ1Nk12dkNNN0V0NTllWVdqcTJWZG1fWDJ6U3lzdF9kNmplOE1EQm1mQWM0?oc=5","date":"2026-03-17","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxNdW1oZlFQeXBCRm4xdGJDR1M0djVrYVJTaGpweldfa3ZQMXJmZ0NmZTRTT3lvbUNOTkNiR3FQc2REcklZN3l4OUw5a2IwamEzRGlha1ZXeXNrSnA5Z04wd21LUHdRQXVZNWZVZWtTNlRNTzg4ZGdzT0Q3dUFKMi1zS3hoMDRFN0V3eEVKeUZERzZaa1hETDJTU3JOOHo2SUNKLVRNdTlPVWpVRVJNZGtfemk2S0N2MTE4WmNsUmhSVW9kZi12d1J0U09LSGJLS1BBWDFIT3ZIN19xdGpveUdfa2pxYUh3NGpKUFk0NHdsN3c3MlJBc3ZWekQ0VDY5dUVkNE0xTER3VnN4MnVET0hZRThkQnlwSXRDbUNzdU0xVjFNcXdXbWdSS1hfM3FkbS1YSVZVMWJaaF8tQmRyLUw5LXFwdkkxbWJoWUMxWVBIQXRvSFdvSG9V?oc=5","date":"2026-03-02","type":"deal","source":"GlobeNewswire","summary":"Egle Therapeutics and Consortium Partners Awarded €8 Million Grant from Horizon Europe to Advance Clinical Development of EGL-001 in Neoadjuvant Head and Neck Cancer - GlobeNewswire","headline":"Egle Therapeutics and Consortium Partners Awarded €8 Million Grant from Horizon Europe to Advance Clinical Development o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPellmQlE5aURaaXY0ZmkxV3RKalRBZDhvQXM0NnVUV1Y1clpBMWdTZjY3ZjZoWkQtZ1BYbjNROWVBUS1SN3lHWTd0QzNyTm4xeGZ1Z1MwWnZ4NWQzNmlUZVU4Y2ExY2h6ZllQQVhNWG5ucXhVaXRZMkFPZmI3bTM5ZkJLR2s1MjFwb3JYVW9WQnZhR2VDdjVWTndOcXIxeTc4UDcyVDJ6YVNoWmZ5SGl3ZUxCVVpMRE00QlZ6OW1HMkxLaTg?oc=5","date":"2026-01-19","type":"pipeline","source":"AD HOC NEWS","summary":"The Truth About Eagle Pharmaceuticals: Is EGRX the Comeback Story No One Saw Coming? - AD HOC NEWS","headline":"The Truth About Eagle Pharmaceuticals: Is EGRX the Comeback Story No One Saw Coming?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPYUpBN1RXLWcxb01fSl9YbmhLWURwb0s2dXRucXAwWnVSN0VWUG9tbjJWQTZkRnRfWHhVVEkwOHdXd2hiSThBdGJnVGN2Q3AzUkZyQXNqWnNNZDZ3cm9aNjgwLXN2LUlXYUJfU2dNdm5RQ3lVWjZaV1ZsQVZuaXQtSFhEMzNMUUt3YVNCMDlKbzRxazVzUTFObG5RY1BUQmls?oc=5","date":"2026-01-09","type":"pipeline","source":"statnews.com","summary":"Up and down the ladder: The latest comings and goings - statnews.com","headline":"Up and down the ladder: The latest comings and goings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNWTVqLXV3VVRtcW1YRXJsLWFUUklla1AzUnA4MzFwR0JMcy0zaV9GWDctYUxFTHJrRW10TUtwOG91dVBNR3dLZkhhQjlKZXZ1MlRfUGYzNXFRMVgtN3FnTXJIRHU3UEhqVVFmd0lsWWNoV3NsSXJRTEc4el8zaWJUQVh5Y3NMaTRNUi11VQ?oc=5","date":"2026-01-07","type":"pipeline","source":"Yahoo Finance","summary":"Egle Therapeutics Appoints John Celebi as Chief Executive Officer - Yahoo Finance","headline":"Egle Therapeutics Appoints John Celebi as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxNTEVkNklZTUdDSzVEVG9zTGVjMjk4VVM4eC1aQVFOc1B6bjYxNDVXRzItVWF3M3QwVTZMRElDVVRtM3dSWF9VMlVRMnAyRlpqc25kZWNCWFpGUmVEN0xOemx1U0Q1RXctdzNuY0F0RmhsbUUwQXdVTFlvV0lIdWRfdXZRbXJsUkpKbUNyV3hORW1PN25vbzE2MU04RGxSSjFHM0laS2NCbnlMQ3lmZFdsUTVQUWFZTGR2UzZWaGdKa0E1YU1yZU4zTi12SVUyTnpvMWJnYVJxU2M1bElsZ0tsOUM2dGtEbEhjOXJfT0hjY01zaTQ3VmExcXlZQW9GaFdyM0FRRlZwVmhUOUhiOXpzVTlxaw?oc=5","date":"2025-12-02","type":"trial","source":"businesswire.com","summary":"Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis - businesswire.com","headline":"Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxObWZxd1djMG9VeVFVY25oNVpaWkw5QU1TMWlPOFU5V3VRaE9lYTktTzRwVzM3LWFTbXNHUGJub1poS0did0FHTUV0Yk1BOFp4M1BhcmVvRjJkU1h5LWl5aWgwWFlLZmRHbklLalpsZDRLQjNBenVyN3RzZW5jM0Y3NWZKWmpYc09TRWFMeUNyTDFPc0ZhRUFvbFVWUUtTVmlXdnp0R1hDS3NuR0hXd0VSSnZzVGFRT2tfU2pObi1fdmR0UlpMTkk4?oc=5","date":"2025-08-20","type":"pipeline","source":"State of Michigan (.gov)","summary":"National Rules for Healthcare Pharmaceutical Disposal Prohibit Sewering for Disposal - State of Michigan (.gov)","headline":"National Rules for Healthcare Pharmaceutical Disposal Prohibit Sewering for Disposal - State of Michigan (.gov)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNRTBTVzRqRFM5cWo4dG5lTURwOTdYb2hLeEc0VWlDV1puWVZJZm1tNEV4eUVMbkdxYlhZT2NGOVNVV2F5R3NwOFI0TlRnM0pIVmlHd2ZxZ0tZaDNhUWZkQ05VOHJpMVdaeVk2clV1ZDAwMjdack1PWUhHaWVpSnA1MW1BMnhMR1cyRGlGRzNUdnJVMUtZVGhKVzdqSQ?oc=5","date":"2025-03-21","type":"pipeline","source":"Yahoo Finance","summary":"Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan - Yahoo Finance","headline":"Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNMzlDeDdnV2ExaG1EcEo0SUVtMUdKZE0tUVlmaTRiTHlLVVVYMUVySm9ndE5kdUE3R0YtR3YyaWVLYUZxeDA1aEJkUExRYmhxSFBsWHB1N0pQYUt2T0hpVWdtdVUwUWNheTVHUlQ5ODR4N0tQOEZDdEJkMWFNblVzOG9DcVlJWTQ?oc=5","date":"2021-10-26","type":"pipeline","source":"European Biotechnology Magazine","summary":"€40m for Treg starver start-up - European Biotechnology Magazine","headline":"€40m for Treg starver start-up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOc1dxckdkUzV5clh0WFFXUGRuTE1USzhyanh1ZUJHQ0s5OTVMQ3Y3eTlrMHI3bU5JbDJwZ2owdksxV3oyX2V6RjB2NTlRRWxaeS1Pc2dwdGhjTEZNUXFEdlJYdndJOVNTWE9Qbl9KaFk1VU1nYzE1WDBCT0NuUHpVVjQ3TFMwVU53bHBmSDBTVXpScTRjay1iQ3RlR0pHZkhQaG5HbWozUzRHUzFVMlMySTBHdlhSMkdxUUNvNEhfSHpsZw?oc=5","date":"2021-10-22","type":"pipeline","source":"Fierce Biotech","summary":"Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform - Fierce Biotech","headline":"Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNYVU0eG9UYi02b1dRV1RjQmNOTWJKMW12Mld4ZFFPTnA4NWVvOUdYRVlralNJT0M2dU5FcG1SazF0M2MxZkJfTjhYdFpUSVdIeFlsbjV2cHVIVENnZ1g5Q1Y0cTdhN1VtLWg4N3ZnMEYzcl9aWThiWmdWWW16WXVYY2NxX2hFV2Y1cmxmbjJlZnJaY3R3Q1RBWndLOXo1RHppUkszRGdjWUMtMW51bXUxNmw0cHliQnRVelF4SGpUMFJpTnFzbWl3b191QXQ1SlVHbkN4MS1BM1lFckV2N092M3JzSU9MWklaWHl1QnMzelBwbmV0YjBqZFlBeGUzQlhRR2hlLVhEUk5RSFV4TzRPMkprTXNhRXdw?oc=5","date":"2021-10-22","type":"regulatory","source":"businesswire.com","summary":"Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers - businesswire.com","headline":"Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-star","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQaW1zUVN3ZWxfRzFpNVBVeFJhc1lldjVrQXFhOElmV2hTSDBmT1BqdmlCSDFoVjJOWjVraDZ0c3RsLVQyVm1uclBuVzhLRF96V2dnUGt5U3pEamRqdjZfbUJQTkZYSzdRSVg3U2RwdzdQNElNUGxkYW0tam9zUUNsd0ZTOURkUWh6V1IxQzEyNVYyUEhhbTVOWDdXRG50WXdoa0NqR2RoaWE2U181ZlpiYg?oc=5","date":"2020-06-11","type":"deal","source":"Fierce Biotech","summary":"Shiny new startup Egle grabs a deal with Takeda for cancer research - Fierce Biotech","headline":"Shiny new startup Egle grabs a deal with Takeda for cancer research","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}